Latest News
AccuVein to Exhibit Leading Vein Visualization Technology at The Anesthesiology 2017 Annual Meeting
AccuVein Inc., the global leader in vein visualization, will be displaying their AccuVein AV400 vein finding technology at The Anesthesiology 2017 Annual Meeting, being held in Boston on October 21-25.
AccuVein’s flagship product, the AccuVein, helps healthcare professionals locate veins by displaying a map of the patient’s vasculature directly on the surface of the skin. Locating peripheral vasculature is invaluable for anesthesiologists and other healthcare professionals who need to start IV’s. The device also facilitates accessing veins for blood draws, sclerotherapy procedures and avoiding veins in cosmetic procedures, helping to minimize bruising.
“AccuVein’s leading vein visualization technology is being embraced by anesthesiologists around the globe for medical and dental procedures,” said Vinny Luciano, AccuVein’s V.P. of Marketing. “Our participation in The Anesthesiology Annual Meeting will help us continue to make inroads in this important market.”
The Anesthesiology Annual Meeting attendees will see the AccuVein at AccuVein’s booth #3532. More information about AccuVein for IV procedures can be found at www.accuvein.com/iv-insertion/.
About AccuVein Inc.
AccuVein Inc. is the global leader in vein visualization technology. AccuVein’s flagship product, the AccuVein, is the world’s only hand-held, non-contact vein illumination solution. The device has won numerous awards including the prestigious Prism Award for Photonics Innovation. It allows healthcare professionals to see a map of peripheral veins on the skin’s surface with the goal of accessing or avoiding veins. It is built on proprietary technology as embodied in its growing patent portfolio that covers a broad range of imaging and medical diagnostic technologies. AccuVein is in use at more than 5,000 facilities and available for sale in over 130 countries worldwide. To see a demonstration of AccuVein in action, please visit www.accuvein.com.